HROW - Harrow Inc Debt to Book Capitalization Ratio

The price trajectory of Harrow, Inc. (HROW) reflects the dynamics of a company whose success relies on management's expertise in acquisitions and profit optimization. The environmental agenda requires the implementation of biodegradable packaging and strict waste control, with the indicator standing at 19.06. Primary threats are linked to logistical disruptions, brand merger complexities, and production quality oversight.

HROW (Harrow Corp) Debt to Book Value history from 07/04/2022 to 10/28/2026

Metric breakdowns and analytics for Harrow Inc (HROW)

- price and consensus price forecast:

Stock Price Harrow, Inc.|HROW - Analyst Consensus Forecast

- market capitalization data:

Market Value Harrow Corp|HROW - Value Adjusted for Debt and Cash

- book capitalization data:

Net Assets per Single Share Harrow|HROW - Company Net Assets|Market Capitalization to Book Value Ratio harrowinc.com|HROW - Company Total Assets

- debt and liquidity data:

Total Debt to Equity Ratio Harrow, Inc.|HROW - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Harrow Health|HROW - Company Cumulative Debt|Debt to Book Value Harrow Corp

Analysis of all company metrics:Harrow, Inc. - HROW

Given Harrow, Inc. (HROW) moderate reliance on external distributors, monitoring borrowed funds relative to balance sheet equity allows for an assessment of the stability of its pharmaceutical model. This indicator compares total liabilities to equity, determining the business's degree of autonomy from creditors and the risks of asset impairment amid monetary policy tightening or inefficient use of financial leverage.

Competitors of Harrow, Inc.